TOP2A and soft tissue sarcoma: In the present study, we analyze the expression of TOP2A and SIRT1 in a large and well-characterized cohort of high-risk soft tissue sarcoma patients with a long-term follow-up and correlate our findings with clinical tumor characteristics and survival data.